Delivery Order SPE2DB22D2206-SPE2DB23FKB24
Award Date 8/31/23
Potential Completion Date 9/1/23
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,647 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562125290 MONOVISC 88 MG/4 ML SYRINGE 4ML. The order is for the delivery of MONOVISC, a viscosupplementation product used to treat osteoarthritis of the knee. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will perform as the prime contractor. The place of performance is their facility in Conshohocken, Pennsylvania. The period of performance...
- The Defense Logistics Agency awarded a $4,647 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562114960 MONOVISC 88 MG/4 ML SYRINGE 4ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements between September 11-12, 2023. As a leading provider of medical supplies to the Department of Defense, this order for MONOVISC, a hyaluronic acid...
- The Defense Logistics Agency awarded a $5,021 delivery order to Amerisourcebergen Drug Corporation for the purchase of MONOVISC 88 MG/4 ML SYRINGES. As the prime contractor, Amerisourcebergen will deliver 4 ML syringes of MONOVISC to the DLA under a firm fixed price contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. No subcontractors or set aside designations were identified. The DLA manages the global supply...
- The Defense Logistics Agency awarded a $25,863 delivery order to Amerisourcebergen Drug Corporation for MONOVISC 88 MG/4 ML SYRINGE 4ML under a firm fixed price contract. Performance will take place in Conshohocken, Pennsylvania from September 15 to 18, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring everything from medical supplies to aircraft and vehicle parts. This delivery order supports the agency's logistics...
- The Defense Logistics Agency awarded a $27,808 delivery order to Amerisourcebergen Drug Corporation for MONOVISC 88 MG/4 ML SYRINGE 4ML. The firm fixed price order is being carried out under DLA's prime vendor program and calls for the delivery of pharmaceutical products to a facility in Conshohocken, Pennsylvania. Performance will take place from September 7-8, 2023. Amerisourcebergen will serve as the prime contractor, with no major subcontractors mentioned. The order was funded by DLA to...
- The Defense Logistics Agency awarded a $10,420.73 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4562521312 MONOVISC 88 MG/4 ML SYRINGE 4ML products. Place of performance will be in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. The contract completion date is October 19, 2023. This delivery order was issued against an existing DLA vehicle to supply joint base medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,821.66 to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. MONOVISC is a hyaluronic acid injection used for the treatment of osteoarthritis knee...
- The Defense Logistics Agency awarded a $5,231 delivery order to Amerisourcebergen Drug Corporation for MONOVISC 88 MG/4 ML SYRINGE 4ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in September 2023. No set aside designation or subcontractors were identified....
- The Defense Logistics Agency awarded a $4,647 delivery order to Amerisourcebergen Drug Corporation for MONOVISC 88 MG/4 ML SYRINGE 4ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four day period from September 18-19, 2023. No set aside designation or subcontractors...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for MONOVISC 88 mg/4 mL syringes with a ceiling value of $6,716.43. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 28, 2025. MONOVISC is a hyaluronic acid injection used to treat osteoarthritis pain, typically administered as an intra-articular injection. The award is performed at AmerisourceBergen's Conshohocken, Pennsylvania location, the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKB24Delivery Order
The Defense Logistics Agency awarded a $5,467 delivery order to Amerisourcebergen Drug Corporation for MONOVISC 88 MG/4 ML SYRINGES. As the prime contractor, Amerisourcebergen will supply 4mL syringes of MONOVISC, a viscosupplementation product used to treat osteoarthritis of the knee, to the DLA under a firm fixed price contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 31 to September 1, 2023. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA-wide vehicle for pharmaceuticals and medical supplies to support the Agency's mission of providing the military services with critical logistics support.
Generated 12/23/23, 9:46 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/31/23 |